How much is Ovid Therapeutics worth in 2026?

Ovid Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Ovid Therapeutics raised?

Ovid Therapeutics has raised N/A in total funding across 1 funding rounds.

Ovid Therapeutics

Biotechnology

Ovid Therapeutics valuation and funding history | Last updated: November 12, 2025 | 1 funding rounds

Current Valuation

N/A

As of November 12, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$175.0M

Last Funding

Nov 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 12, 2025	PIPE	$175.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Ovid Therapeutics is currently valued at N/A as of November 12, 2025.

Track Ovid Therapeutics Valuation Updates

Get notified when Ovid Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Ovid Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Ovid Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Ovid Therapeutics Worth in 2026?

Ovid Therapeutics is a leading private company in the Biotechnology sector. Track Ovid Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Ovid Therapeutics Valuation is Determined

Private company valuations like Ovid Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.